12 investors have funded 8 Life Sciences companies head-officed in Leipzig, across 18 rounds (Mar 2007 – Aug 2018). They are ranked by how many Leipzig companies in this market they have actually backed.
"In Leipzig" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | TGFS | Leipzig, Germany | Seed | 2 | 3 | — | Jun 2012 | 56 |
| 2 | HTGF | Bonn, Germany | SeedSeries A | 2 | 2 | 1 | Sep 2014 | 672 |
| 3 | Beteiligungsmanagement Thuringen | Erfurt, Germany | SeedSeries B | 2 | 2 | — | Aug 2018 | 44 |
| 4 | MIG Capital | Munich, Germany | Series A | 1 | 2 | — | May 2009 | 38 |
| 5 | Alfred Wieder | Munich, Germany | Series A | 1 | 2 | — | May 2009 | 1 |
| 6 | Novartis Venture Fund | Basel, Switzerland | Series A | 1 | 1 | — | Jun 2011 | 139 |
| 7 | KfW | Frankfurt Am Main, Germany | Series A | 1 | 1 | — | Nov 2008 | 128 |
| 8 | Capricorn Partners | Leuven, Belgium | Series B | 1 | 1 | 1 | Aug 2018 | 75 |
| 9 | Boehringer Ingelheim Venture Fund | Ingelheim am Rhein, Germany | Series A | 1 | 1 | — | Jun 2011 | 54 |
| 10 | SHS | Tubingen, Germany | Series A | 1 | 1 | — | Nov 2008 | 32 |
| 11 | CFH Management | Leipzig, Germany | Seed | 1 | 1 | — | Dec 2017 | 28 |
| 12 | Elvaston Capital Management | Berlin, Germany | Post-IPO | 1 | 1 | — | Jun 2012 | 19 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Leipzig that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| c-LEcta c-lecta.com |
5 | 5 | — | Series B Aug 2018 |
| Sovicell sovicell.com |
2 | 4 | $2.4M | Series A May 2009 |
| PluriSelect pluriselect.com |
2 | 2 | $1.6M | Seed Mar 2009 |
| AMP Therapeutics amp-therapeutics.com |
2 | 2 | — | Series A Jun 2011 |
| Scienova scienova.com |
1 | 1 | $1.4M | Seed Dec 2008 |
| Vita 34 vita34.de |
1 | 1 | — | Post-IPO Jun 2012 |
| VivoSensMedical vivosensmedical.com |
1 | 2 | — | Seed Jun 2012 |
| Raylytic raylytic.com |
1 | 1 | — | Seed Dec 2017 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Aug 2018 | Beteiligungsmanagement Thuringen | c-LEcta | Series B | — |
| Aug 2018 | Capricorn PartnersLED | c-LEcta | Series B | — |
| Dec 2017 | CFH Management | Raylytic | Seed | — |
| Sep 2014 | HTGFLED | c-LEcta | Series A | — |
| Jun 2012 | TGFS | VivoSensMedical | Seed | — |
| Jun 2012 | Elvaston Capital Management | Vita 34 | Post-IPO | — |
| Jun 2011 | Boehringer Ingelheim Venture Fund | AMP Therapeutics | Series A | — |
| Jun 2011 | TGFS | VivoSensMedical | Seed | — |
| Jun 2011 | Novartis Venture Fund | AMP Therapeutics | Series A | — |
| May 2009 | Alfred Wieder | Sovicell | Series A | — |
| May 2009 | MIG Capital | Sovicell | Series A | — |
| Mar 2009 | TGFS | PluriSelect | Seed | $775.4K |
| Mar 2009 | HTGF | PluriSelect | Seed | $775.4K |
| Dec 2008 | Beteiligungsmanagement Thuringen | Scienova | Seed | $1.4M |
| Nov 2008 | KfW | c-LEcta | Series A | — |
| Nov 2008 | SHS | c-LEcta | Series A | — |
| Mar 2007 | Alfred Wieder | Sovicell | Series A | $1.2M |
| Mar 2007 | MIG Capital | Sovicell | Series A | $1.2M |
Life Sciences investors in other cities